PROPANC BIOPHARMA, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2013
Total Assets: $1.7K
Liabilities Breakdown FY2013
Total Liabilities: $794.2K
Asset Breakdown
Total Assets: $1.7K
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $0 | 0.0% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $538 | 30.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $1.2K | 69.2% |
Liabilities Breakdown
Total Liabilities: $794.2K
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $272.6K | 34.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $521.6K | 65.7% |